| PERIOD ENDING | 4-Jan-09 | 6-Jan-08 | 31-Dec-06 | | Total Revenue | 218,406 | 197,043 | 191,499 | | Cost of Revenue | 89,714 | 82,363 | 75,618 | | | Gross Profit | 128,692 | 114,680 | 115,881 | | | Operating Expenses | | Research Development | 65,658 | 63,726 | 56,926 | | Selling General and Administrative | 63,145 | 63,053 | 67,959 | | Non Recurring | 2,424 |
-
|
-
| | Others | 796 |
-
| 15 | | | | Total Operating Expenses | 132,023 |
-
|
-
| | | | Operating Income or Loss | (3,331) | (12,099) | (9,019) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 5,433 | 8,607 | 7,128 | | Earnings Before Interest And Taxes | 2,102 | (3,492) | (1,891) | | Interest Expense |
-
|
-
|
-
| | Income Before Tax | 2,102 | (3,492) | (1,891) | | Income Tax Expense | 13,827 | (588) | 264 | | Minority Interest |
-
|
-
|
-
| | | | Net Income From Continuing Ops | (11,725) | (2,904) | (2,155) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
| | Other Items |
-
|
-
|
-
| | | | Net Income | (11,725) | (2,904) | (2,155) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($11,725) | ($2,904) | ($2,155) |
|
1.48% Nasdaq 
Income Statement
